MAX BioPharma reports on the Inhibition of Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells by its Oxysterol Drug Candidate, Oxy210

Paper available from https://pubmed.ncbi.nlm.nih.gov/39404395/